Value Set OID: 2.16.840.1.114222.4.11.837

Ethnicity

Measure	Description
CMS117v10	Childhood Immunization Status
CMS117v5	Childhood Immunization Status
CMS117v6	Childhood Immunization Status
CMS117v7	Childhood Immunization Status
CMS117v8	Childhood Immunization Status
CMS117v9	Childhood Immunization Status
CMS122v10	Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS122v5	Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS122v6	Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS122v7	Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS122v8	Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS122v9	Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS123v5	Diabetes: Foot Exam
CMS123v6	Diabetes: Foot Exam
CMS124v10	Cervical Cancer Screening
CMS124v5	Cervical Cancer Screening
CMS124v6	Cervical Cancer Screening
CMS124v7	Cervical Cancer Screening
CMS124v8	Cervical Cancer Screening
CMS124v9	Cervical Cancer Screening
CMS125v10	Breast Cancer Screening
CMS125v5	Breast Cancer Screening
CMS125v6	Breast Cancer Screening
CMS125v7	Breast Cancer Screening
CMS125v8	Breast Cancer Screening
CMS125v9	Breast Cancer Screening
CMS127v10	Pneumococcal Vaccination Status for Older Adults
CMS127v5	Pneumococcal Vaccination Status for Older Adults
CMS127v6	Pneumococcal Vaccination Status for Older Adults
CMS127v7	Pneumococcal Vaccination Status for Older Adults
CMS127v8	Pneumococcal Vaccination Status for Older Adults
CMS127v9	Pneumococcal Vaccination Status for Older Adults
CMS128v10	Anti-depressant Medication Management
CMS128v5	Anti-depressant Medication Management
CMS128v6	Anti-depressant Medication Management
CMS128v7	Anti-depressant Medication Management
CMS128v8	Anti-depressant Medication Management
CMS128v9	Anti-depressant Medication Management
CMS129v10	Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS129v11	Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS129v6	Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS129v7	Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS129v8	Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS129v9	Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS130v10	Colorectal Cancer Screening
CMS130v5	Colorectal Cancer Screening
CMS130v6	Colorectal Cancer Screening
CMS130v7	Colorectal Cancer Screening
CMS130v8	Colorectal Cancer Screening
CMS130v9	Colorectal Cancer Screening
CMS131v10	Diabetes: Eye Exam
CMS131v5	Diabetes: Eye Exam
CMS131v6	Diabetes: Eye Exam
CMS131v7	Diabetes: Eye Exam
CMS131v8	Diabetes: Eye Exam
CMS131v9	Diabetes: Eye Exam
CMS132v5	Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS132v6	Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS132v7	Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS132v8	Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS133v10	Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS133v5	Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS133v6	Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS133v7	Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS133v8	Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS133v9	Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS134v10	Diabetes: Medical Attention for Nephropathy
CMS134v5	Diabetes: Medical Attention for Nephropathy
CMS134v6	Diabetes: Medical Attention for Nephropathy
CMS134v7	Diabetes: Medical Attention for Nephropathy
CMS134v8	Diabetes: Medical Attention for Nephropathy
CMS134v9	Diabetes: Medical Attention for Nephropathy
CMS135v10	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS135v5	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS135v6	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS135v7	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS135v8	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS135v9	Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS136v10	Follow-Up Care for Children Prescribed ADHD Medication (ADD)
CMS136v11	Follow-Up Care for Children Prescribed ADHD Medication (ADD)
CMS136v6	ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication
CMS136v7	Follow-Up Care for Children Prescribed ADHD Medication (ADD)
CMS136v8	Follow-Up Care for Children Prescribed ADHD Medication (ADD)
CMS136v9	Follow-Up Care for Children Prescribed ADHD Medication (ADD)
CMS137v10	Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS137v5	Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS137v6	Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS137v7	Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS137v8	Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS137v9	Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS138v10	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS138v5	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS138v6	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS138v7	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS138v8	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS138v9	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS139v10	Falls: Screening for Future Fall Risk
CMS139v5	Falls: Screening for Future Fall Risk
CMS139v6	Falls: Screening for Future Fall Risk
CMS139v7	Falls: Screening for Future Fall Risk
CMS139v8	Falls: Screening for Future Fall Risk
CMS139v9	Falls: Screening for Future Fall Risk
CMS142v10	Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS142v5	Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS142v6	Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS142v7	Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS142v8	Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS142v9	Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS143v10	Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS143v5	Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS143v6	Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS143v7	Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS143v8	Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS143v9	Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS144v10	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS144v5	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS144v6	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS144v7	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS144v8	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS144v9	Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS145v10	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
CMS145v5	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
CMS145v6	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
CMS145v7	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
CMS145v8	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
CMS145v9	Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
CMS146v10	Appropriate Testing for Pharyngitis
CMS146v5	Appropriate Testing for Children with Pharyngitis
CMS146v6	Appropriate Testing for Children with Pharyngitis
CMS146v7	Appropriate Testing for Children with Pharyngitis
CMS146v8	Appropriate Testing for Children with Pharyngitis
CMS146v9	Appropriate Testing for Pharyngitis
CMS147v10	Preventive Care and Screening: Influenza Immunization
CMS147v11	Preventive Care and Screening: Influenza Immunization
CMS147v6	Preventive Care and Screening: Influenza Immunization
CMS147v7	Preventive Care and Screening: Influenza Immunization
CMS147v8	Preventive Care and Screening: Influenza Immunization
CMS147v9	Preventive Care and Screening: Influenza Immunization
CMS149v10	Dementia: Cognitive Assessment
CMS149v5	Dementia: Cognitive Assessment
CMS149v6	Dementia: Cognitive Assessment
CMS149v7	Dementia: Cognitive Assessment
CMS149v8	Dementia: Cognitive Assessment
CMS153v10	Chlamydia Screening for Women
CMS153v5	Chlamydia Screening for Women
CMS153v6	Chlamydia Screening for Women
CMS153v7	Chlamydia Screening for Women
CMS153v8	Chlamydia Screening for Women
CMS153v9	Chlamydia Screening for Women
CMS154v10	Appropriate Treatment for Upper Respiratory Infection (URI)
CMS154v5	Appropriate Treatment for Children with Upper Respiratory Infection (URI)
CMS154v6	Appropriate Treatment for Children with Upper Respiratory Infection (URI)
CMS154v7	Appropriate Treatment for Children with Upper Respiratory Infection (URI)
CMS154v8	Appropriate Treatment for Children with Upper Respiratory Infection (URI)
CMS154v9	Appropriate Treatment for Upper Respiratory Infection (URI)
CMS155v10	Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents
CMS155v5	Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS155v6	Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS155v7	Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS155v8	Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS155v9	Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS156v10	Use of High-Risk Medications in Older Adults
CMS156v5	Use of High-Risk Medications in the Elderly
CMS156v6	Use of High-Risk Medications in the Elderly
CMS156v7	Use of High-Risk Medications in the Elderly
CMS156v8	Use of High-Risk Medications in the Elderly
CMS156v9	Use of High-Risk Medications in Older Adults
CMS157v10	Oncology: Medical and Radiation - Pain Intensity Quantified
CMS157v5	Oncology: Medical and Radiation - Pain Intensity Quantified
CMS157v6	Oncology: Medical and Radiation - Pain Intensity Quantified
CMS157v7	Oncology: Medical and Radiation - Pain Intensity Quantified
CMS157v8	Oncology: Medical and Radiation - Pain Intensity Quantified
CMS157v9	Oncology: Medical and Radiation - Pain Intensity Quantified
CMS158v5	Pregnant women that had HBsAg testing
CMS158v6	Pregnant women that had HBsAg testing
CMS159v10	Depression Remission at Twelve Months
CMS159v5	Depression Remission at Twelve Months
CMS159v6	Depression Remission at Twelve Months
CMS159v7	Depression Remission at Twelve Months
CMS159v8	Depression Remission at Twelve Months
CMS159v9	Depression Remission at Twelve Months
CMS160v5	Depression Utilization of the PHQ-9 Tool
CMS160v6	Depression Utilization of the PHQ-9 Tool
CMS160v7	Depression Utilization of the PHQ-9 Tool
CMS160v8	Depression Utilization of the PHQ-9 Tool
CMS161v10	Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS161v5	Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS161v6	Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS161v7	Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS161v8	Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS161v9	Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS164v5	Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet
CMS164v6	Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet
CMS165v10	Controlling High Blood Pressure
CMS165v5	Controlling High Blood Pressure
CMS165v6	Controlling High Blood Pressure
CMS165v7	Controlling High Blood Pressure
CMS165v8	Controlling High Blood Pressure
CMS165v9	Controlling High Blood Pressure
CMS166v6	Use of Imaging Studies for Low Back Pain
CMS166v7	Use of Imaging Studies for Low Back Pain
CMS167v5	Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
CMS167v6	Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
CMS169v5	Bipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance use
CMS169v6	Bipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance use
CMS177v10	Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS177v5	Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS177v6	Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS177v7	Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS177v8	Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS177v9	Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS22v10	Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS22v5	Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS22v6	Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS22v7	Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS22v8	Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS22v9	Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS249v1	Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
CMS249v2	Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
CMS249v3	Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
CMS249v4	Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
CMS2v10	Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS2v11	Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS2v6	Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS2v7	Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS2v8	Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS2v9	Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS347v1	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS347v2	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS347v3	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS347v4	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS347v5	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS349v1	HIV Screening
CMS349v2	HIV Screening
CMS349v3	HIV Screening
CMS349v4	HIV Screening
CMS50v10	Closing the Referral Loop: Receipt of Specialist Report
CMS50v5	Closing the Referral Loop: Receipt of Specialist Report
CMS50v6	Closing the Referral Loop: Receipt of Specialist Report
CMS50v7	Closing the Referral Loop: Receipt of Specialist Report
CMS50v8	Closing the Referral Loop: Receipt of Specialist Report
CMS50v9	Closing the Referral Loop: Receipt of Specialist Report
CMS52v5	HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
CMS52v6	HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
CMS52v7	HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
CMS52v8	HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
CMS56v10	Functional Status Assessment for Total Hip Replacement
CMS56v5	Functional Status Assessment for Total Hip Replacement
CMS56v6	Functional Status Assessment for Total Hip Replacement
CMS56v7	Functional Status Assessment for Total Hip Replacement
CMS56v8	Functional Status Assessment for Total Hip Replacement
CMS56v9	Functional Status Assessment for Total Hip Replacement
CMS645v1	Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
CMS645v2	Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
CMS645v3	Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
CMS645v4	Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
CMS645v5	Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
CMS646v2	Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
CMS65v6	Hypertension: Improvement in Blood Pressure
CMS65v7	Hypertension: Improvement in Blood Pressure
CMS66v10	Functional Status Assessment for Total Knee Replacement
CMS66v5	Functional Status Assessment for Total Knee Replacement
CMS66v6	Functional Status Assessment for Total Knee Replacement
CMS66v7	Functional Status Assessment for Total Knee Replacement
CMS66v8	Functional Status Assessment for Total Knee Replacement
CMS66v9	Functional Status Assessment for Total Knee Replacement
CMS68v10	Documentation of Current Medications in the Medical Record
CMS68v11	Documentation of Current Medications in the Medical Record
CMS68v6	Documentation of Current Medications in the Medical Record
CMS68v7	Documentation of Current Medications in the Medical Record
CMS68v8	Documentation of Current Medications in the Medical Record
CMS68v9	Documentation of Current Medications in the Medical Record
CMS69v10	Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS69v5	Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS69v6	Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS69v7	Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS69v8	Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS69v9	Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS74v10	Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS74v11	Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS74v6	Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS74v7	Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS74v8	Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS74v9	Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS75v10	Children Who Have Dental Decay or Cavities
CMS75v5	Children Who Have Dental Decay or Cavities
CMS75v6	Children Who Have Dental Decay or Cavities
CMS75v7	Children Who Have Dental Decay or Cavities
CMS75v8	Children Who Have Dental Decay or Cavities
CMS75v9	Children Who Have Dental Decay or Cavities
CMS771v1	International Prostate Symptom Score (IPSS) or American Urological Association-Symptom Index (AUA-SI) Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
CMS771v2	Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
CMS771v3	Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
CMS82v4	Maternal Depression Screening
CMS82v5	Maternal Depression Screening
CMS82v6	Maternal Depression Screening
CMS82v7	Maternal Depression Screening
CMS90v10	Functional Status Assessments for Congestive Heart Failure
CMS90v11	Functional Status Assessments for Heart Failure
CMS90v6	Functional Status Assessments for Congestive Heart Failure
CMS90v7	Functional Status Assessments for Congestive Heart Failure
CMS90v8	Functional Status Assessments for Congestive Heart Failure
CMS90v9	Functional Status Assessments for Congestive Heart Failure

MedicalCodify.com